{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:33:52Z","timestamp":1786718032655,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0028-3886.173638","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T08:20:32Z","timestamp":1461745232000},"page":"45","source":"Crossref","is-referenced-by-count":23,"title":["Coexistence of autoimmune diseases and autoantibodies in patients with myasthenia gravis"],"prefix":"10.4103","volume":"64","author":[{"given":"Sibel","family":"Tamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HafizeNalan","family":"Gokce Gunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Gokcal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TahirKurtulus","family":"Yoldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.173638-1","first-page":"1","volume-title":"Myasthenia gravis: Paradox versus paradigm in autoimmunity","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"key-10.4103\/0028-3886.173638-2","first-page":"445","volume-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0028-3886.173638-3","first-page":"351","volume-title":"Autoimmune myasthenia gravis","author":"Gilhus","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"key-10.4103\/0028-3886.173638-4","first-page":"413","volume-title":"Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes","author":"Berrih-Aknin","year":"2014","journal-title":"Rev Med Interne"},{"key":"key-10.4103\/0028-3886.173638-5","first-page":"e32487","volume-title":"Population based study of 12 autoimmune diseases in Sardinia, Italy: Prevalence and comorbidity","author":"Sardu","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/0028-3886.173638-6","first-page":"594","volume-title":"The autoimmune spectrum of myasthenia gravis: A Swedish population-based study","author":"Fang","year":"2015","journal-title":"J Intern Med"},{"key":"key-10.4103\/0028-3886.173638-7","first-page":"121","volume-title":"Frequency of autoimmune diseases in myasthenia gravis: A systematic review","author":"Mao","year":"2011","journal-title":"Int J Neurosci"},{"key":"key-10.4103\/0028-3886.173638-8","first-page":"16","volume-title":"Myasthenia gravis: Recommendations for clinical research standards.Task force of the medical scientific advisory board of the myasthenia gravis foundation of America","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.173638-9","first-page":"1271","volume-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0028-3886.173638-10","first-page":"235","volume-title":"A patient with coexisting myasthenia gravis and Lambert-Eaton myasthenic syndrome","author":"Kim","year":"2012","journal-title":"J Clin Neurol"},{"key":"key-10.4103\/0028-3886.173638-11","first-page":"1251","volume-title":"Reproductive and menopausal factors and risk of systemic lupus erythematosus in women","author":"Costenbader","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0028-3886.173638-12","first-page":"54","volume-title":"Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis","author":"Karlson","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0028-3886.173638-13","first-page":"33","volume-title":"The etiology of autoimmune diseases: The case of myasthenia gravis","author":"Bach","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0028-3886.173638-14","first-page":"17","volume-title":"Myasthenia gravis and risks for comorbidity","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol"},{"key":"key-10.4103\/0028-3886.173638-15","first-page":"124","volume-title":"Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease","author":"Toth","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"key-10.4103\/0028-3886.173638-16","first-page":"1168","volume-title":"Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan","author":"Matsui","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.173638-17","first-page":"1290","volume-title":"The association of systemic lupus erythematosus and myasthenia gravis: A series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"key-10.4103\/0028-3886.173638-18","first-page":"170","volume-title":"Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan","author":"Chen","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"key-10.4103\/0028-3886.173638-19","first-page":"1403","volume-title":"Clinical features of patients with myasthenia gravis associated with autoimmune diseases","author":"Kanazawa","year":"2007","journal-title":"Eur J Neurol"},{"key":"key-10.4103\/0028-3886.173638-20","first-page":"4","volume-title":"High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: A clinical and serologic study","author":"Sthoeger","year":"2006","journal-title":"Am J Med Sci"},{"key":"key-10.4103\/0028-3886.173638-21","first-page":"582","volume-title":"Systemic lupus erythematosus and myasthenia gravis","author":"Hrycek","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"key-10.4103\/0028-3886.173638-22","first-page":"94","volume-title":"Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine","author":"Poulas","year":"2012","journal-title":"J Neuroimmunol"},{"key":"key-10.4103\/0028-3886.173638-23","first-page":"76","volume-title":"Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis","author":"Ogaki","year":"2012","journal-title":"Neurologist"},{"key":"key-10.4103\/0028-3886.173638-24","first-page":"87","volume-title":"Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica","author":"McKeon","year":"2009","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.173638-25","first-page":"1601","volume-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients","author":"Leite","year":"2012","journal-title":"Neurology"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:30:29Z","timestamp":1786714229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.173638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["173638"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.173638","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}